Skip to content

Identifying the Right Technology for Your Multiparty Business Processes

Blockchain Technology Partners offers infrastructure choices for distributed, multiparty workflows. In this guest blog, Csilla Zsigri, VP, Marketing and Strategy at Blockchain Technology Partners explains the suitability of the various technology options. Identifying the right technology for digitizing processes that involve multiple parties within and across organizations, has plagued businesses for decades. Information technology and

Tackling Counterfeit Drugs in the Global Pharma Supply Chain

Global sales for counterfeit drugs cost businesses billions of dollars per year. Drug counterfeiting affects human lives, business reputation, and return on investment for the entire pharmaceutical industry. According to the World Health Organization, it is estimated that up to 30% of pharmaceutical products sold in emerging markets are counterfeit, and about 1 million people

Components of a Successful Blockchain Project Part II: Fabric, Daml, and Catalyst

In our last blog post, Components of a Successful Blockchain Project Part 1, we discussed how Daml, Cord and Catalyst provide greater efficiency and technological innovation to financial services organizations. To continue the discussion, Robert van Donge from IntellectEU explains how Hyperledger Fabric, Daml, and Catalyst offer another route for businesses seeking a solution for

How to Streamline and Accelerate Clinical Trials

Conducting clinical trials is a time consuming, expensive affair that involves close collaboration between multiple stakeholders (parties), often geographically distributed, and one that needs a high level of monitoring, regulation, and precision to maintain patient privacy and auditability. In this two-part blog series, Lakshmi Shastry, Principal Solutions Architect at Brillio, explains the challenges around clinical

Components of a Successful Blockchain Project: Daml, Corda, and Catalyst

To bring greater efficiency and technological innovation to financial services organizations,  IntellectEU is leveraging three key technologies: Corda, Daml, and Catalyst. In this guest blog, Robert van Donge, Sales Lead, Catalyst Blockchain Platform at IntellectEU, explains how IntellectEU is driving successful blockchain adoption and digital transformation initiatives for the world’s largest exchanges, investment banks, and

Deploy an end-to-end digital asset trading platform in 20 minutes

Digital Asset and Exberry have teamed up with Baymarkets to add clearing to their end-to-end digital asset exchange platform. For the first time, and with the integration of Baymarkets Clara Clearing System, market participants can register, trade and clear traditional, alternative and digital assets on one integrated platform. Exberry (the exchange technology pioneer), Digital Asset

Digital Asset Shapes Future of Interoperable Applications

With a growing customer base and partner ecosystem, 2020 was a banner year for Digital Asset; our customer base tripled and our partner ecosystem doubled in size.  Daml is an open source smart contract language used by developers to write and deploy full-stack, distributed applications for DLT, blockchain, or databases in days. It is purpose-built

Accelerate Blockchain Adoption Across the Supply Chain

Supply chains are extremely complex, involving multiple parties across local and global boundaries, operating across disparate platforms for payments, resource management, shipping, and much more. Duncan Johnston-Watt, Founder and CEO at Blockchain Technology Partners, explains how Sextant for Daml can accelerate blockchain adoption across the supply chain. To date, most supply chains run on centralized databases

Improve Pharmaceutical Efficiency and Transparency with Daml Driven Solutions for Supply Chains and Patient Data

Chander Damodaran from Brillio discusses how Daml smart contracts can accelerate the collaboration and automation of multiparty business processes in clinical trials and pharma supply chains As 2021 begins to take flight, the entire world has turned their attention to Moderna, Pfizer-BioNTech, and many other pharmaceutical organizations to slow the spread of COVID-19 and its

Get notified of updates